EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs AISBL was founded in autumn 2008.[1] It is a trans-European Association for Pharmaceutical Entrepreneurs. Its goal is to support and to promote members of the pharmaceutical industry in all stages of the development of new products, including the fields:

• Scientific objectives
• Legal aspects
• Technical standards
• Economical possibilities

Emphasis is put on the interpretation and the communication of International Regulations and Legislation towards its Members.

Structure

• President of the Association: Jan G. Smith, ABIGO Medial AB, Sweden.
• Vice-President: Dr. Bernd Wegener, B.R.A.H.M.S AG, Germany.
• Vice-President: Stefano Bonani, SEGIX ITALIA srl, Italy
• Treasurer: Dr. Sigurd Pütter, Arzneimittel Pütter GmbH & Co. KG, Germany
• Secretary General: Dr. Alexander Natz

Policy Objectives

EUCOPE is active in the above mentioned areas:

• Transparent reimbursement and pricing decisions
• Fast national marketing authorisation procedures
• Incentives for incremental research
• Public perception of pharmaceutical innovations by SMEs
• Increased need for collaboration
• Community patent and strong intellectual property rights
• Recast of the clinical trials legislation
• Informed patient as political objective
• Effective promotion of R&D by tax incentives
• Reduced VAT rates for pharmaceuticals
• Prevention of late payment by public authorities

External links

• EUCOPE
• Pharmaceutical Unit of the European Commission
• Pharmaceutical Forum of the European Commission
• Environment, Public Health and Food Safety Committee of the European Parliament
• Industry, Research and Energy Committee of the European Parliament